ORIGINAL ARTICLEVascular changes in the periosteum of congenital pseudarthrosis of the tibia☆
Introduction
Congenital pseudarthrosis of the tibia (CPT) is characterized by recurrent pathologic fractures of the lower leg in early childhood. Callus formation fails, and bone healing tends to be insufficient [5], [6], [28]. Usually, the first symptom of CPT is antero-lateral bowing of the tibia and secondary bowing of the fibula. X-ray examination reveals focal cortical sclerosis and broadening of the tibia and the fibula, with the apex of the bowing between the middle and the lower third of the diaphysis (prefracture state). The periosteum is markedly thickened in the region where the pseudarthrosis develops. Fracture of either the tibia or the fibula occurs spontaneously or follows a minor trauma. Consecutive bone healing is insufficient, with development of fibrous tissue forming the pseudarthrosis.
Numerous models of pathogenesis such as mechanical stress [9], [24], neurofibroma interfering with bone union [12], or abnormalities of the blood vessels feeding the tibia [34] have been proposed. However, these features were neither found consistently in CPT patients nor could they conclusively explain the clinical and pathologic properties of CPT. The periosteal cuff surrounding the CPT may play a major role in the advent of the bone lesion [23]. Pseudarthrosis was induced in rats by cellophane stripes [19] and in the rabbit by placing a synthetic Marlex-Mesh® around the tibia, mimicking the thickened periosteum in CPT [33]. In agreement with these findings, CPT healing rates were higher when the pathologic periosteum and fibromatous tissue were entirely removed [2], [32].
Up to 50–75% of patients with CPT show clinical symptoms of neurofibromatosis type I (NF1; von Recklinghausen's disease) [16], [18]. The character of the correlation between both diseases is unknown. NF1 is caused by germline mutations (one out of two is sporadic) or somatic mosaicism in the neurofibromin gene on the long arm of chromosome 17 [11], [29]. The phenotype of NF1 mutations varies considerably, including typical benign skin tumors and café au lait spots, as well as gliomas of the optic and acoustic nerves [22].
The purpose of this study was to analyze and compare the pathomorphology of the periosteum and tibial pseudarthrosis of CPT patients with and without NF. In addition, we attempted to evaluate the role of the thickened periosteum in the set up of CPT.
Section snippets
Patients
We investigated four children (one female and three males) with CPT, their age ranging between 8 and 13 years. The initial fracture of the tibia was noted during the first 3 years of life. Three patients were diagnosed with NF1 based on clinical diagnostic criteria defined by the National Neurofibromatosis Foundation (www.nf.org), whereas one patient did not have NF1, but was affected by additional fibrous dysplasia.
As a control case, we used operation specimens from a 2-year-old girl suffering
Gross findings
From all patients, we received tissue samples consisting of the pseudarthrotic bone and the surrounding periosteum (Fig. 2A). Macroscopic investigations revealed similar findings in all four patients, irrespective of suffering from NF1 or not. These were asymmetric thickening of the bone corticalis and concentric broadening of the periosteum (Fig. 2B). The compactae were discontinuous, and the spongiosae lacked the normal trabecular structure. A reactive bone marrow fibrosis was observed in all
Discussion
All four patients investigated had pseudarthrosis of the tibia, which was surrounded by concentric thickening of the periosteum. Callus formation was lacking, and bone healing was insufficient. Interestingly, the occurrence of nerval structures in the altered periosteum and the related changes in periosteal small blood vessels could be identified in all four patients, irrespective of suffering from NF1 or not, but were not seen in the control patient.
Fibrous thickening of the periosteum
References (34)
- et al.
Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1
Blood
(1998) - et al.
Pseudarthrosis of the rabbit tibiaa model for congenital pseudarthrosis?
J. Pediatr. Orthop.
(1991) The possible relationship of neurofibromatosis, congenital pseudarthrosis, and fibular dysplasia
J. Bone Jt. Surg.
(1950)- et al.
Problems in the surgical treatment of congenital pseudarthrosis of the lower leg
Z. Orthop.
(1989) - et al.
Proteins regulating Ras and its relatives
Nature
(1993) - et al.
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
Nat. Genet.
(1996) Pathology and natural history of congenital pseudarthrosis of the tibia
Clin. Orthop.
(1982)- et al.
Congenital pseudarthrosis of the tibia
J. Bone Jt. Surg.
(1958) - et al.
Ultrastructure of congenital pseudarthrosis of the tibia
Arch. Pathol.
(1973) - et al.
Congenital pseudarthrosis of long bonesa clinical, radiographic, histologic and ultrastructural study
Clin. Orthop.
(1977)
Congenital pseudarthrosis of the tibia treated by the intramedullary nail
J. Bone Jt. Surg.
Congenital pseudarthrosis of the tibiatreatment by transfer of the ipsilateral fibula with vascular pedicle
J. Pediatr. Orthop.
Somatic mosaicism in a patient with neurofibromatosis type 1
Am. J. Hum. Genet.
Neurofibromatosis
Ilizarov technique in the treatment of congenital pseudarthrosis of the tibia
J. Pediatr. Orthop.
Vascularized fibular grafting for the treatment of congenital pseudarthrosis of the tibia
Orthopedics
Ilizarov treatment of congenital pseudarthroses of the tibia
J. Pediatr. Orthop.
Cited by (0)
- ☆
The study was supported by the START programme of the Medical Faculty, RWTH Aachen (14/2000).